Trial of Treatment Protocol for Smoking Cessation

January 30, 2018 updated by: Sunju Park, Daejeon University

Trial of Treatment Protocol for Smoking Cessation: A Pragmatic Randomized Controlled Pilot Study

Background: As smoking regulatory policies, including the WHO FCTC (Framework Convention on Tobacco Control), are enforcing, demand for smoking cessation treatment is being increased.

According the trend, development and evaluation of the medical guideline, Induced participation of medical personnel and available in Korean medical clinic, is needed. Purpose: To evaluate the satisfaction and effect of traditional & complementary medicine (T&CM) tobacco control program Methods: Recruited subjects were divided into control and test groups. They treated two times a week during the first three weeks and once a week during the last week.

Program participation rates and drop rates, satisfaction, amount of smoking before and after programs

, smoking-related key variables, nicotine dependence test (Fagerstrom test), Expired CO amounts, urinary cotinine amount, withdrawal symptoms, the change in quality of life(EQ-5D) are measured.

Study Overview

Detailed Description

Subjects in control group are treated NRT and counselling. Nicotine Replacement Therapy is provided 7 patches and 30 gums once a week for 4 weeks. Using amounts are depend on each subject's cravings. (Investigator will check how much they used.) Doctor consults about 10-15 minutes per visit.

Subjects in intervention group are treated NRT, counselling and traditional & complementary medicine treatment (Body acupuncture, Ear acupuncture and aromatic therapy). Body acupoints are HT7, LI4, ST36, LU7, LU6 on both sides. Ear acupoints are Shenmen, Lung, Pharynx, Trachea, Endocrine. Subjects are treated with acupuncture for 20 minutes per visit and put ear acupuncture like sticker for 1-2 days. Mixture oil of Lavender, peppermint, rosemary are used to massage behind the ears. It is used 2 times a day and they can adjust frequency depending on their cravings.(Investigator will check how much they used.)

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Daejeon, Korea, Republic of, 35235
        • Dunsan Korean Medicine Hospital of Daejeon University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 1) having willing to stop smoking 2) currently smoking and applying one of the following

Exclusion Criteria:

  • 1) suffering in the last 2 weeks cardiovascular disease or Severe arrhythmias, unstable angina 2) suffering from severe arrhythmia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
NRT, counselling, traditional & complementary medicine treatment (Body acupuncture, Ear acupuncture and aromatic therapy).
Body acupuncture, Ear acupuncture and aromatic therapy
Nicotine Replacement Therapy, counselling
Active Comparator: Control group
NRT, counselling
Nicotine Replacement Therapy, counselling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Continuous Abstinence Rate
Time Frame: 4 week
endpoint of treatment
4 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
7-day Point Prevalence Abstinence
Time Frame: 6,8,12,16,24 week
follow-up measure
6,8,12,16,24 week
Prolonged Abstinence Rate
Time Frame: 3,6 month
follow-up measure
3,6 month
Program participation rate
Time Frame: 0,7,10,14,17 day, 3,4,6,8,12,16,24 week
each treatment and follow-up
0,7,10,14,17 day, 3,4,6,8,12,16,24 week
Amount of smoking
Time Frame: 0,7,10,14,17 day, 3,4,6,8,12,16,24 week
each treatment and follow-up
0,7,10,14,17 day, 3,4,6,8,12,16,24 week
Tobacco craving
Time Frame: 0,7,10,14,17 day, 3,4,6,8,12,16,24 week
each treatment and follow-up
0,7,10,14,17 day, 3,4,6,8,12,16,24 week
Exhaled Carbon monoxide monoxide
Time Frame: 0,7,10,14,17 day, 3,4,6,8,12,16,24 week
each treatment and follow-up
0,7,10,14,17 day, 3,4,6,8,12,16,24 week
Quality of life
Time Frame: 0,4 week
beginning and endpoint of treatment
0,4 week
Nicotine dependence test (Fagerstrom test)
Time Frame: 10, 17 day, 4week
10, 17 day, 4week
Withdrawal symptoms
Time Frame: 1,2,3,4 week
1,2,3,4 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Choong sik Cho, Doctor, Daejeon University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2016

Primary Completion (Actual)

July 1, 2017

Study Completion (Actual)

August 31, 2017

Study Registration Dates

First Submitted

April 28, 2016

First Submitted That Met QC Criteria

May 8, 2016

First Posted (Estimate)

May 11, 2016

Study Record Updates

Last Update Posted (Actual)

February 1, 2018

Last Update Submitted That Met QC Criteria

January 30, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This is confidential.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Traditional & Complementary Medicine treatment

3
Subscribe